FDA Brief

Warning letters Biologics

FDA warning letter to

RenatiLabs Inc.

Issued Jun 1, 2023Posted Aug 1, 2023Division of Biological Products Operations I

Deviations/CFR/Regulations for Human Cells, Tissues & Cellular Products (HCT/Ps). We haven't summarized this letter yet. Read it on fda.gov.